Detalhe da pesquisa
1.
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial.
Lancet Oncol
; 22(6): 883-892, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33989559
2.
Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
J Oncol Pharm Pract
; 26(6): 1390-1396, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31937188
3.
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.
Lancet Oncol
; 20(9): 1295-1305, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31351869
4.
A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.
Invest New Drugs
; 34(4): 481-9, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27225873
5.
A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer.
Invest New Drugs
; 33(6): 1248-56, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26453566
6.
Sex-Specific Survival and Treatment Delay in Oropharyngeal Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg
; 2024 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678390
7.
Interdisciplinary Approach to Expedited Outpatient Gastrostomy Tube Placement in Head and Neck Cancer Patients: A Single Center Retrospective Study.
Acad Radiol
; 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521613
8.
Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy.
Oral Oncol
; 136: 106247, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410204
9.
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(11): 1565-1573, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768670
10.
Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.
Cancer
; 123(22): 4310-4313, 2017 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950413
11.
Inevitable Progress-Relying on the Immune System, Not Chance.
Clin Cancer Res
; 28(3): 435-437, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34848533
12.
A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
Oral Oncol
; 135: 106219, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36279618
13.
Retreatment of Recurrent or Second Primary Head and Neck Cancer After Prior Radiation: Executive Summary of the American Radium Society Appropriate Use Criteria.
Int J Radiat Oncol Biol Phys
; 113(4): 759-786, 2022 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398456
14.
Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients.
Head Neck
; 43(11): 3530-3539, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34492135
15.
Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
Head Neck
; 43(1): 367-391, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098180
16.
Comparison of Hematologic Toxicity and Bone Marrow Compensatory Response in Head and Neck vs. Cervical Cancer Patients Undergoing Chemoradiotherapy.
Front Oncol
; 10: 1179, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32793487
17.
Adjuvant and Neoadjuvant Treatment of Skin Cancer.
Facial Plast Surg Clin North Am
; 27(1): 139-150, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420067
18.
Cost-effectiveness Analysis of Nivolumab for Treatment of Platinum-Resistant Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck.
J Natl Cancer Inst
; 110(5): 479-485, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29126314
19.
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial.
JAMA Oncol
; 4(11): 1583-1588, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29931076
20.
Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor-Based Immunotherapy.
Clin Cancer Res
; 23(19): 5729-5736, 2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28972084